Skip Navigation

Postponed (Date to be Determined) - ORWH Women's Health Seminar Series: Tomosynthesis Mammographic Imaging Screening Trial (TMIST)

Air date: Thursday, June 20, 2019, 1:00:00 PM
Time displayed is Eastern Time, Washington DC Local
Description: The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) is a randomized breast screening trial that will help researchers learn about the best ways to find breast cancer in women who have no symptoms. It compares two Food and Drug Administration-approved types of digital mammography: standard digital mammography (2-D) with a newer technology called tomosynthesis mammography (3-D). Researchers are doing this trial because they do not know if 3-D mammography is better than 2-D mammography for breast cancer screening.

For more information go to https://orwh.od.nih.gov/
Author: ORWH, NIH
Runtime: 2 hours